-
1
-
-
45949103309
-
The pharmacology and management of the vitamin K antagonists: ACCP evidence-based clinical practice guidelines
-
Ansell J., Hirsh J., Hylek E., Jacobson A., Crowther M., Palareti G. The pharmacology and management of the vitamin K antagonists: ACCP evidence-based clinical practice guidelines. Chest. 2008 ; 133: 160S - 198S.
-
(2008)
Chest
, vol.133
-
-
Ansell, J.1
Hirsh, J.2
Hylek, E.3
Jacobson, A.4
Crowther, M.5
Palareti, G.6
-
2
-
-
0030700392
-
Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers
-
DOI 10.1016/S0006-2952(97)00304-3, PII S0006295297003043
-
Yamazaki H., Shimada T. Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers. Biochem Pharmacol. 1997 ; 54: 1195-1203. (Pubitemid 27497246)
-
(1997)
Biochemical Pharmacology
, vol.54
, Issue.11
, pp. 1195-1203
-
-
Yamazaki, H.1
Shimada, T.2
-
3
-
-
0026519541
-
Hydroxylation of warfarin by human cDNA-expressed cytochrome P450: A role for P-4502C9 in the etiology of (S)-warfarin-drug interactions
-
Rettie AE, Korzekwa KR, Kunze KL, et al. Hydroxylation of warfarin by human cDNA-expressed cytochrome P450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chem Res Toxicol. 1992 ; 5: 54-59.
-
(1992)
Chem Res Toxicol
, vol.5
, pp. 54-59
-
-
Rettie, A.E.1
Korzekwa, K.R.2
Kunze, K.L.3
-
4
-
-
0031015345
-
Human P450 metabolism of warfarin
-
DOI 10.1016/S0163-7258(96)00140-4, PII S0163725896001404
-
Kaminsky LS, Zhang Z. -Y. Human P450 metabolism of warfarin. Pharmacol Ther. 1997 ; 73: 67-74. (Pubitemid 26425815)
-
(1997)
Pharmacology and Therapeutics
, vol.73
, Issue.1
, pp. 67-74
-
-
Kaminsky, L.S.1
Zhang, Z.-Y.2
-
5
-
-
0027452620
-
Correlation of human cytochrome P4502C substrate specificities with primary structure: Warfarin as a probe
-
Kaminsky LS, de Morais SMF, Faletto MB, Dunbar DA, Goldstein JA Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe. Mol Pharmacol. 1993 ; 43: 234-239. (Pubitemid 23055067)
-
(1993)
Molecular Pharmacology
, vol.43
, Issue.2
, pp. 234-239
-
-
Kaminsky, L.S.1
De Morais, S.M.F.2
Faletto, M.B.3
Dunbar, D.A.4
Goldstein, J.A.5
-
6
-
-
19344366484
-
Systematic overview of warfarin and its drug and food interactions
-
DOI 10.1001/archinte.165.10.1095
-
Holbrook AM, Pereira JA, Labiris R., et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005 ; 165: 1095-1106. (Pubitemid 40720733)
-
(2005)
Archives of Internal Medicine
, vol.165
, Issue.10
, pp. 1095-1106
-
-
Holbrook, A.M.1
Pereira, J.A.2
Labiris, R.3
McDonald, H.4
Douketis, J.D.5
Crowther, M.6
Wells, P.S.7
-
7
-
-
0347360102
-
Possible interaction between warfarin and cranberry juice
-
Suvarna R., Pirmohamed M., Henderson L. Possible interaction between warfarin and cranberry juice. BMJ. 2003 ; 327: 1454. (Pubitemid 38045820)
-
(2003)
British Medical Journal
, vol.327
, Issue.7429
, pp. 1454
-
-
Suvarna, R.1
Pirmohamed, M.2
Henderson, L.3
-
8
-
-
4344651322
-
Warfarin and cranberry juice: An interaction
-
Grant P. Warfarin and cranberry juice: an interaction ? J Heart Valve Surg. 2004 ; 13: 25-26.
-
(2004)
J Heart Valve Surg
, vol.13
, pp. 25-26
-
-
Grant, P.1
-
9
-
-
33745853192
-
Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding
-
Rindone JP, Murphy TW Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. Amer J Therap. 2005 ; 13: 283-284.
-
(2005)
Amer J Therap
, vol.13
, pp. 283-284
-
-
Rindone, J.P.1
Murphy, T.W.2
-
10
-
-
34247208182
-
Probable elevation in international normalized ratio from cranberry juice
-
Welch JM, Forster K. Probable elevation in international normalized ratio from cranberry juice. J Pharm Technol. 2007 ; 23: 104-107. (Pubitemid 46608837)
-
(2007)
Journal of Pharmacy Technology
, vol.23
, Issue.2
, pp. 104-107
-
-
Welch, J.M.1
Forster, K.2
-
11
-
-
34848901351
-
Interaction Between Warfarin and Cranberry Juice
-
DOI 10.1016/j.clinthera.2007.08.018, PII S0149291807002536
-
Paeng CH, Sprague M., Jackevicius CA Interaction between warfarin and cranberry juice. Clin Ther. 2007 ; 29: 1730-1735. (Pubitemid 47494551)
-
(2007)
Clinical Therapeutics
, vol.29
, Issue.8
, pp. 1730-1735
-
-
Paeng, C.H.1
Sprague, M.2
Jackevicius, C.A.3
-
12
-
-
14944359308
-
Interaction between warfarin and cranberry juice: New advice
-
Medicines and Healthcare Products Regulatory Agency/ Committee on Safety of Medicines
-
Medicines and Healthcare Products Regulatory Agency/ Committee on Safety of Medicines. Interaction between warfarin and cranberry juice: new advice. Curr Probl Pharmacovigilance. 2003 ; 30: 10
-
(2003)
Curr Probl Pharmacovigilance.
, vol.30
, pp. 10
-
-
-
14
-
-
29244466817
-
Comparative pharmacokinetics of vitamin K antagonists warfarin, phenprocoumon and acenocoumarol
-
DOI 10.2165/00003088-200544120-00003
-
Ufer M. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol. Clin Pharmacokinet. 2005 ; 44: 1227-1246. (Pubitemid 41832565)
-
(2005)
Clinical Pharmacokinetics
, vol.44
, Issue.12
, pp. 1227-1246
-
-
Ufer, M.1
-
15
-
-
33748197015
-
Interaction between warfarin and cranberry juice
-
DOI 10.1592/phco.26.9.1314
-
Aston JL, Lodolce AE, Shapiro NL Interaction between warfarin and cranberry juice. Pharmacotherapy. 2006 ; 26: 1314-1319. (Pubitemid 44313758)
-
(2006)
Pharmacotherapy
, vol.26
, pp. 1314-1319
-
-
Aston, J.L.1
Lodolce, A.E.2
Shapiro, N.L.3
-
16
-
-
33847394490
-
Interaction potential between cranberry juice and warfarin
-
DOI 10.2146/ajhp060370
-
Pham DQ, Pham AQ Interaction potential between cranberry juice and warfarin. Am J Health Syst Pharm. 2007 ; 64: 490-494. (Pubitemid 46339262)
-
(2007)
American Journal of Health-System Pharmacy
, vol.64
, Issue.5
, pp. 490-494
-
-
Pham, D.Q.1
Pham, A.Q.2
-
17
-
-
16844373618
-
Interaction of warfarin with drugs, natural substances, and foods
-
DOI 10.1177/0091270004271404
-
Greenblatt DJ, von Moltke LL Interaction of warfarin with drugs, natural substances, and foods. J Clin Pharmacol. 2005 ; 45: 127-132. (Pubitemid 40490435)
-
(2005)
Journal of Clinical Pharmacology
, vol.45
, Issue.2
, pp. 127-132
-
-
Greenblatt, D.J.1
Von Moltke, L.L.2
-
18
-
-
34248992947
-
Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam - Probes of CYP2C9, CYP1A2, and CYP3A4
-
DOI 10.1038/sj.clpt.6100149, PII 6100149
-
Lilja JJ, Backman JT, Neuvonen PJ Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam: probes of CYP2C9, CYP1A2, and CYP3A4. Clin Pharmacol Therap. 2007 ; 81: 833-839. (Pubitemid 46788294)
-
(2007)
Clinical Pharmacology and Therapeutics
, vol.81
, Issue.6
, pp. 833-839
-
-
Lilja, J.J.1
Backman, J.T.2
Neuvonen, P.J.3
-
19
-
-
33751177098
-
Cranberry Does Not Affect Prothrombin Time in Male Subjects on Warfarin
-
DOI 10.1016/j.jada.2006.09.012, PII S0002822306020943
-
Li Z., Seeram NP, Carpenter CL, Thames G., Minutti C., Bowerman S. Cranberry does not affect prothrombin time in male subjects on warfarin. J Am Diet Assoc. 2006 ; 106: 2057-2061. (Pubitemid 44779450)
-
(2006)
Journal of the American Dietetic Association
, vol.106
, Issue.12
, pp. 2057-2061
-
-
Li, Z.1
Seeram, N.P.2
Carpenter, C.L.3
Thames, G.4
Minutti, C.5
Bowerman, S.6
-
20
-
-
49449094988
-
Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects
-
Abdul MI, Jiang X., Williams KM, et al. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol. 2008 ; 154: 1691-1700.
-
(2008)
Br J Pharmacol
, vol.154
, pp. 1691-1700
-
-
Abdul, M.I.1
Jiang, X.2
Williams, K.M.3
-
21
-
-
30444445695
-
Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: In vitro and clinical studies
-
DOI 10.1016/j.clpt.2005.09.014, PII S0009923605004340
-
Greenblatt DJ, von Moltke LL, Perloff ES, Luo Y., Harmatz JS, Zinny MA Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clin Pharmacol Ther. 2006 ; 79: 125-133. (Pubitemid 43071237)
-
(2006)
Clinical Pharmacology and Therapeutics
, vol.79
, Issue.1
, pp. 125-133
-
-
Greenblatt, D.J.1
Von Moltke, L.L.2
Perloff, E.S.3
Luo, Y.4
Harmatz, J.S.5
Zinny, M.A.6
|